Bill Doyle, Executive Chairman, Novocure Ltd.
Dekel Gelbman, CEO, FDNA
Bill Doyle is an experienced healthcare executive whose experiences include working at Pershing Square Capital management, running several divisions at Johnson & Johnson, and is currently on the board of startup Blink Health, just to name a few of his accomplishments.
Dekel Gelman is CEO of DNA, whose technology is used by 70% of the world’s geneticists in over 130 countries. FDNA’s next-generation phenotyping (NGP) technologies analyze complex human physiological data to produce actionable genomic insights.
Join us and find Independent Projects (IPs), summer internships, research projects, and jobs!
Israeli Healthcare Entrepreneurship Forum: Professor Regina Herzlinger (HBS) and her husband George (MIT, PhD, Physics) are hosting and sponsoring a new forum, which will create an intimate environment for discussion and synergistic matches between Israeli start-ups and Harvard talent, and create opportunities for independent projects and full-time employment.
RSVP HERE